Cystic fibrosis drug tested for similar lung condition
NCT ID NCT05743946
Summary
This study tested whether Trikafta, a drug approved for cystic fibrosis, could help people with non-cystic fibrosis bronchiectasis (NCFBE), a different lung condition with similar symptoms. Thirty-two adults with NCFBE took Trikafta for four weeks while researchers measured their lung function, quality of life, and collected optional skin or blood samples to study how their cells responded to the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Emory Clinic
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.